← Leaderboards
Anlys Olivera
Emory University
$90,095
Attributed
$90,095
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36K · FY2008–10$50K$37.5K$25K$12.5K$0
'08
'09
'10
Funding mix
By agency
NIH$90,095 · 1
By mechanism
F31$90,095 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Haian Fu$16,783,892
- Raymond J Dingledine$29,610,268
- Kathy K Griendling$20,428,027
- Craig M. Coopersmith$17,572,303
- James Gibson Else$12,717,755
Others in their field
Top investigators on “Cytokine Signaling”
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Mitchell Kronenberg · Cedars-Sinai Medical Center$31,296,598
- Joren C Madsen · Massachusetts General Hospital$27,590,431
- Lionel B Ivashkiv · Hospital For Special Surgery$27,101,801
- Joshua A Boyce · Brigham And Women'S Hospital$24,526,829
- Pearl T Toy · University Of California San Francisco$22,097,475
Research focus
Cytokine SignalingAdultCytokine GeneAcuteAnalogAnimalsAftercareAntidepressive AgentsAnti-InflammatoryAnti-Inflammatory AgentsBaseB-DnaBehaviorBehavioralBehavior AssessmentBiological AvailabilityBrainBrain RegionBrain TissueCharacteristicsConsumptionCurcuminCytokineDatabases
Grant awards (3)
Effects of UBS109, a novel NF-kappaBeta inhibitor, on depressive-like behaviors$24,954
F31 · FY2010 · MH · contact PI
Effects of UBS109, a novel NF-kappaBeta inhibitor, on depressive-like behaviors$29,118
F31 · FY2009 · MH · contact PI
Effects of UBS109, a novel NF-kappaBeta inhibitor, on depressive-like behaviors$36,023
F31 · FY2008 · MH · contact PI